MP67-19 THE NUCLEAR GRADE AND PROGNOSIS ARE UNRELATED TO THE TNM STAGE IN MULTILOCULAR CYSTIC RENAL CELL NEOPLASM OF LOW MALIGNANT POTENTIAL
Teng Li,Kan Gong,Xianghui Ning,Shuanghe Peng,Jiangyi Wang,Qun He,Xinyu Yang
DOI: https://doi.org/10.1016/j.juro.2017.02.2055
2017-01-01
Abstract:You have accessJournal of UrologyKidney Cancer: Epidemiology & Evaluation/Staging II1 Apr 2017MP67-19 THE NUCLEAR GRADE AND PROGNOSIS ARE UNRELATED TO THE TNM STAGE IN MULTILOCULAR CYSTIC RENAL CELL NEOPLASM OF LOW MALIGNANT POTENTIAL Teng Li, Kan Gong, Xianghui Ning, Shuanghe Peng, Jiangyi Wang, Qun He, and Xinyu Yang Teng LiTeng Li More articles by this author , Kan GongKan Gong More articles by this author , Xianghui NingXianghui Ning More articles by this author , Shuanghe PengShuanghe Peng More articles by this author , Jiangyi WangJiangyi Wang More articles by this author , Qun HeQun He More articles by this author , and Xinyu YangXinyu Yang More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.2055AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Multilocular cystic clear cell renal cell neoplasm of low malignant potential or multilocular cystic renal cell carcinoma (MCRCC) is a rare distinct subtype of clear cell renal cell carcinoma (RCC). As a rare subtype of renal cell carcinoma, this disease was mostly reported in literature as small cases series, some features about this disease remains unclear, an unresolved issue is whether this disease should be staged as other types of RCCs due to its low nuclear grade and minimal tumor burden. The present study aimed to characterize the clinical and pathologic features of MCRCC. METHODS From January 2006 to December 2014, 76 cases were identified as MCRCC among 4345 patients with RCC at our institution. Their clinical and characteristics, surgical management, pathologic features, and outcomes were retrospectively reviewed. RESULTS The incidence of MCRCC in our patients with RCC was 1.7%. The mean age at diagnosis was 46.7±10.5 years (range,18 to 80 years). Most cases showed no symptoms. Nuclear grade was unrelated to the TNM stage (P=0.451). Of these 76 patients, 66 (86.8%) were followed up for a median of 52 months, and no tumor recurrence or metastasis was found, no differences were found in the prognosis of different TNM groups. CONCLUSIONS The incidence of MCRCC in patients with RCC is low. The nuclear grade and prognosis of MCRCC cases was unrelated to the TNM stage, suggesting that the current stage criteria might not suitable for this lesion. Patients with MCRCC have an excellent prognosis; thus, the follow-up interval after surgery can be longer to minimize unnecessary examinations. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e878-e879 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Teng Li More articles by this author Kan Gong More articles by this author Xianghui Ning More articles by this author Shuanghe Peng More articles by this author Jiangyi Wang More articles by this author Qun He More articles by this author Xinyu Yang More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...